Philip Morris set to realize its vision for a Smoke-Free future

Wed, May 22, 2019 | By publisher


Health

PHILIP Morris International Inc., PMI, NYSE:PM, has announced leadership moves to accelerate the realization of its vision of a smoke-free future and further enhance business growth.

The company has created the following new roles: Chief Consumer Officer (CCO), Chief Life Sciences Officer (CLSO), Chief Product Officer (CPO) and Chief New Ventures Officer (CNVO).

“Since the launch of our smoke-free product, IQOS, in 2014, we have made enormous progress both in terms of organizational capabilities, know-how and in our business results. With IQOS commercialized in 47 markets today, we are extremely proud of what has been achieved to date, including two recent milestones: realizing 10 million users and the U.S. FDA authorization to commercialize this smoke-free alternative in the U.S.,” said André Calantzopoulos, PMI’s Chief Executive Officer.

“To accelerate, we must further enhance our ability to stay at the forefront of technology, science and consumer centricity,” he said.

All four executive positions will report to Calantzopoulos as part of PMI’s Senior Management Team (SMT). Three of the four are new hires who will replace the current role of President Science & Innovation, currently held by Mirek Zielinski, who will assume the new role of Chief New Ventures Officer.

The role of CCO will be filled by Stefano Volpetti, an expert marketer in end-to-end brand building with more than two decades of international experience working across different markets in a variety of roles.

According to the statement by the company, Volpetti will be responsible for grouping all consumer-facing experiences across the consumer journey—connecting with legal age smokers to drive change—from trends and insights, product and brand portfolio architecture, and consumer communications, to channel strategy.

Stepping into the role of CLSO will be John O’Mullane, a broad integrative thinker, who has led innovation and R&D across all of the significant consumer healthcare categories.

“He will build upon PMI’s unique scientific capabilities in RRPs and outline the company’s scientific strategy for new products and services that go beyond tobacco and nicotine and will combine scientific excellence with commercial rigor to elevate the business transformation,” the statement  said.

The statement added that the CPO role has been filled by an experienced leader from the electronics industry and will be announced in the forthcoming weeks. The CPO will be accountable for the development and acceleration of the company’s innovative smoke-free product pipeline, related technologies and electronic devices manufacturing.

“It is both humbling and reassuring that we are able to attract senior executives of such deep experience, credibility and expertise,” said Charles Bendotti, Senior Vice President People & Culture, PMI.

“We look forward to their contributions in accelerating business success and achieving our vision,” he said.

BE

– May 22, 2019 @ 15:24 GMT |

Tags: